Use access key #2 to skip to page content.
$35.08 -0.33 (-0.93%)
10/10/2008 4:04 PM

GlaxoSmithKline plc (ADR) (GSK)

CAPS Rating:
*****

The Company is a global healthcare group which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter medicines and health-related consumer products.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating GSK

Add Stock to Watchlist

What the Community Thinks

Total Members

870 Outperforms
55 Underperforms
 

All-Stars

284 Outperforms
13 Underperforms
 

Wall Street

9 Outperforms
3 Underperforms
 

Members bullish on GSK are also bullish on:

Members bearish on GSK are also bearish on:

Ticker Tags

Behemoth (33), Mega Cap (145), Dividend (206), Drug Manufacturers - Major (27), Optionable (32), United Kingdom (50), Buffett Stock (50), Bird Flu (8), Multinational Company (16), Big Pharma (12)
Suggest a tag

GlaxoSmithKline plc (ADR) At A Glance

Current Price: $35.08
Last Trade Time: 10/10/2008 4:04 PM
Open: $34.77
Previous Close: $35.41
Daily Range: $32.84 - $35.97
52-Week Range: $35.29 - $54.64
Volume: 6,134,935
Market Cap: $116.20B
P/E Ratio: 15.25
Compare Our Special Broker Offers!

Stock Trends

GSK VS S&P 500 (SPY)

GSK 12 month chart vs. S&P

News & Discussion Boards

Other News Headlines for GSK

More Headlines...

Top Bull Pitch

Recs

6

GlaxoSmithKline plc (ADR) (GSK)

Avatar TMFBreakerJava (99.32) Submitted: 6/30/08 9:57 PM

Glaxo Smith Kline is a diversified multinational drug maker with a long and profitable history. They recently acquired a favorite of mine, Sirtris Pharmaceuticals. Sirtris is pursuing research into anti-aging properties of the Sirtuin genes which are activated by Resveratrol, a component found in ...More

Replies: 1 | Reply | Permalink

Top Bear Pitch

Recs

1

GlaxoSmithKline plc (ADR) (GSK)

Avatar Tak3natheFlood (33.13) Submitted: 9/25/08 7:48 PM

I see many downsides to this pharmaceutical. The company is shrinking with free cash flows suffering. A Democratic government will not be friendly to prescription drug companies in the future. Any new developments don't help the bottom line unless they materialize and even then the shear size of the...More

Replies: 0 | Reply | Permalink

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 170 :   1 2 3 4 5 Next » Jump to page:

Recs

0

 (GSK)

Avatar redneckdemon (55.27) Submitted: 10/09/08 10:20 PM : Outperform Start Price: $34.77 GSK Score: -1.11

Another cheap five star dressed for success.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (GSK)

Avatar awallejr (< 20) Submitted: 10/02/08 12:17 PM : Outperform Start Price: $43.21 GSK Score: 3.00

Aging/dividend play

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (GSK)

Avatar guccirati (88.19) Submitted: 10/01/08 7:57 AM : Outperform Start Price: $42.87 GSK Score: 4.98

This stock is part of my long term income strategy.

10yield.com

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (GSK)

Avatar gee156 (< 20) Submitted: 9/29/08 2:33 PM : Outperform Start Price: $42.34 GSK Score: 5.01

I owned it and it made me money , still wish I could buy more

Report this Post Replies: 0 | Reply | Permalink

Recs

1

 (GSK)

Avatar Tak3natheFlood (33.13) Submitted: 9/25/08 7:48 PM : Underperform Start Price: $44.86 GSK Score: -3.72

I see many downsides to this pharmaceutical. The company is shrinking with free cash flows suffering. A Democratic government will not be friendly to prescription drug companies in the future. Any new developments don't help the bottom line unless they materialize and even then the shear size of the company hinders any real growth. "A bird in the hand is better than two in the bush." Easy underperform.

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 170 :   1 2 3 4 5 Next » Jump to page:

Wall Street

Results 1 - 12 of 12  

picks per page. CHANGE Expand All Pitches

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackBillNygren 96.25 06/19/08 Outperform 5Y $43.49-19.34%-34.02%+14.67 Toggle the visibility of 60-Second Pitch and replies
TrackBerkowitz 79.05 05/27/08 Outperform 1Y $43.29-18.96%-35.78%+16.82 Toggle the visibility of 60-Second Pitch and replies
TrackJimCramer 81.55 05/05/08 Underperform 3W $44.40-21.00%-37.16%-16.16
TrackUBS 83.70 02/11/08 Outperform NS $41.29-15.05%-33.51%+18.46
TrackDodgeCox 97.91 09/30/07 Outperform NS $50.75-30.88%-42.00%+11.12 Toggle the visibility of 60-Second Pitch and replies
TrackJohnKeeley 85.85 09/30/07 Outperform NS $50.75-30.88%-42.00%+11.12 Toggle the visibility of 60-Second Pitch and replies
TrackBrandes < 20 09/30/07 Outperform NS $50.75-30.88%-42.00%+11.12 Toggle the visibility of 60-Second Pitch and replies
TrackNWQ < 20 09/30/07 Outperform NS $50.75-30.88%-42.00%+11.12 Toggle the visibility of 60-Second Pitch and replies
TrackSnow 96.33 09/30/07 Outperform NS $50.75-30.88%-42.00%+11.12 Toggle the visibility of 60-Second Pitch and replies
TrackEdwardOwens 99.52 09/30/07 Outperform NS $50.75-30.88%-42.00%+11.12 Toggle the visibility of 60-Second Pitch and replies
TrackBearStearns 89.07 07/25/07 Underperform NS $50.27-30.22%-41.78%-11.57
TrackJPMorgan 21.18 03/22/07 Underperform NS $52.04-32.59%-38.32%-5.72

Results 1 - 12 of 12  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners